← All organizations

Trimeris

For profitContributed to NME

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Jun 1, 2007

Acquired by Synageva Biopharma → Alexion → AstraZeneca on Jan 1, 2011

Timeline

1990s

Jan 1, 1993
Trimeris— Founded

2010s

Jan 1, 2011
Synageva Biopharma— Acquired By

2020s

Oct 13, 2020
AstraZeneca— Now

Drugs by trial phase (11 distinct, 12 trials)

Phase 4 (8 own, 0 via acquisition)

Phase 2 (3 own, 0 via acquisition)

Indications

Studied for

Recent trials (12)

NCT00488059CollaboratorPhase 4Jun 1, 2007
NCT00337701CollaboratorPhase 4Jun 1, 2006
NCT00326963CollaboratorPhase 4Mar 1, 2006
NCT00233883CollaboratorPhase 4Aug 1, 2005
NCT00086710Lead sponsorPhase 1Jul 8, 2004
NCT00089492CollaboratorPhase 2Jul 1, 2004
NCT00048217Lead sponsorPhase 1/Phase 2Oct 28, 2002
NCT00022763CollaboratorPhase 2Aug 1, 2001
NCT00021554CollaboratorPhase 3Jul 21, 2001
NCT00008528CollaboratorPhase 3Jan 12, 2001
NCT00002228Lead sponsorPhase 2Nov 2, 1999
NCT00002239CollaboratorPhase 2May 1, 1999

Details

Founded: Durham, NC, US Jan 1, 1993
Last known activity: Jun 1, 2007